Bluejay Therapeutics announced it raised $20.5 Million in an initial filing from an offering of $41.2 Million
Bluejay Therapeutics announced it raised $20.5 Million in an initial filing from an offering of $41.2 Million
08/16/22, 5:49 PM
Location
san mateoMoney raised
$20.5 million
Industry
information technology
Company Info
Location
951 mariners island blvd., suite 300
san mateo, california, united states
Additional Info
The mission of Bluejay Therapeutics is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection. Bluejay has exclusively licensed global rights to advance several HBV programs, including a best-in-class anti-HBsAg monoclonal antibody.